Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Key findings include: Upregulation of VEGFR2 expression and internalization in endothelial cells Activation of the VEGFR2-Akt-eNOS signaling cascade Enhanced endothelial cell proliferation and tube formation Improved collateral circulation in ischemic injury models The peptides pro-angiogenic effects appear particularly relevant in healing scenarios where blood supply restoration is critical for tissue recovery
PubMed laboratory research record [PMID: 5542399] PubMed record related to this compound for laboratory literature review
Your immune system gets confused
Verifiable task number at the lab's website
Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis
US$ 28.21
US$ 21.35
US$ 20.32
US$ 27.99
US$ 21.51
US$ 28.00
US$ 24.55
US$ 29.78
